Back
Calvert US Mid-Cap Core Responsible Index ETF Vs. Akero Therapeutics Industry Stock Comparison
Buy
70
CVMC
Calvert US Mid-Cap Core Responsible Index ETF
Last Price:
$61.24
Seasonality Move:
-5.34%
Buy
53
AKRO
Akero Therapeutics
Last Price:
$48.31
Seasonality Move:
22.59%
Buy
70
Calvert US Mid-Cap Core Responsible Index ETF (CVMC)
is a Buy
Is Calvert US Mid-Cap Core Responsible Index ETF a Buy, Sell or Hold?
-
The current Calvert US Mid-Cap Core Responsible Index ETF [CVMC] share price is $62.99. The Score for CVMC is 70, which is 40% above its historic median score of 50, and infers lower risk than normal.
-
CVMC is currently trading in the 60-70% percentile range relative to its historical Stock Score levels.
-
This Score is currently showing a higher than normal reading, suggesting risk levels may be somewhat lower than normal.
Buy
53
Akero Therapeutics (AKRO)
is a Buy
Is Akero Therapeutics a Buy, Sell or Hold?
-
The current Akero Therapeutics [AKRO] share price is $48.31. The Score for AKRO is 53, which is 6% above its historic median score of 50, and infers lower risk than normal.
-
AKRO is currently trading in the 50-60% percentile range relative to its historical Stock Score levels.
-
This Score is currently showing a higher than normal reading, suggesting risk levels may be somewhat lower than normal.
CVMC Stock Price Chart
What is Calvert US Mid-Cap Core Responsible Index ETF's stock price today?
-
The Calvert US Mid-Cap Core Responsible Index ETF share price today is $62.99The current trend is moderately bearish and CVMC is experiencing buying pressure, which is a positive indicator for future bullish movement.
AKRO Stock Price Chart
What is Akero Therapeutics's stock price today?
-
The Akero Therapeutics share price today is $48.31Based on the share price being below its 5, 20 & 50 day exponential moving averages, the current trend is considered strongly bearish and AKRO is experiencing slight buying pressure.
CVMC Technical Analysis
| Chart Indicators | Level | Buy or Sell |
|---|---|---|
| MACD (12, 26): | 0.23 | Buy |
| Relative Strength Index (14 RSI): | 62.68 | Buy |
| Chaikin Money Flow: | 4625 | - |
| Bollinger Bands | Level | Buy or Sell |
|---|---|---|
| Bollinger Bands (25): | (61.17 - 62.41) | Buy |
| Bollinger Bands (100): | (55.63 - 61.75) | Buy |
AKRO Technical Analysis
| Chart Indicators | Level | Buy or Sell |
|---|---|---|
| MACD (12, 26): | -0.72 | Sell |
| Relative Strength Index (14 RSI): | 42.94 | Sell |
| Chaikin Money Flow: | 176266 | - |
| Bollinger Bands | Level | Buy or Sell |
|---|---|---|
| Bollinger Bands (25): | (48.58 - 52.42) | Sell |
| Bollinger Bands (100): | (40.79 - 53.07) | Buy |
CVMC Moving Averages
| Moving Averages | Level | Buy or Sell |
|---|---|---|
| 8-day SMA: | 61.66 | Buy |
| 20-day SMA: | 61.9 | Buy |
| 50-day SMA: | 61 | Buy |
| 200-day SMA: | 59.77 | Buy |
| 8-day EMA: | 61.87 | Buy |
| 20-day EMA: | 61.71 | Buy |
| 50-day EMA: | 60.91 | Buy |
| 200-day EMA: | 59.24 | Buy |
AKRO Moving Averages
| Moving Averages | Level | Buy or Sell |
|---|---|---|
| 8-day SMA: | 49.56 | Sell |
| 20-day SMA: | 50.04 | Sell |
| 50-day SMA: | 52.07 | Sell |
| 200-day SMA: | 41.69 | Buy |
| 8-day EMA: | 49.14 | Sell |
| 20-day EMA: | 49.91 | Sell |
| 50-day EMA: | 49.95 | Sell |
| 200-day EMA: | 42.9 | Buy |
Calvert US Mid-Cap Core Responsible Index ETF Earnings Growth & CVMC Earnings Dates
-
Analysts estimate an earnings decrease this quarter of $0.00 per share, a decrease next quarter of $0.00 per share, a decrease this year of $0.00 per share, and a decrease next year of $0.00 per share.
Akero Therapeutics Earnings Growth & AKRO Earnings Dates
-
Analysts estimate an earnings increase this quarter of $0.02 per share, a decrease next quarter of $0.13 per share, an increase this year of $0.23 per share, and a decrease next year of $0.61 per share.
Calvert US Mid-Cap Core Responsible Index ETF Technical Analysis
| Jul 31 | Aug 1 | Aug 4 | Aug 5 | Aug 6 | Aug 7 | Aug 8 | Aug 11 | Aug 12 | Aug 13 | |
|---|---|---|---|---|---|---|---|---|---|---|
| Jul | Aug | |||||||||
| 31 | 01 | 04 | 05 | 06 | 07 | 08 | 11 | 12 | 13 | |
| Technical Analysis: Buy or Sell? | ||||||||||
| 8-day SMA: | ||||||||||
| 20-day SMA: | ||||||||||
| 50-day SMA: | ||||||||||
| 200-day SMA: | ||||||||||
| 8-day EMA: | ||||||||||
| 20-day EMA: | ||||||||||
| 50-day EMA: | ||||||||||
| 200-day EMA: | ||||||||||
| MACD (12, 26): | ||||||||||
| Relative Strength Index (14 RSI): | ||||||||||
| Bollinger Bands (25): | ||||||||||
| Bollinger Bands (100): | ||||||||||
Akero Therapeutics Technical Analysis
| Jul 31 | Aug 1 | Aug 4 | Aug 5 | Aug 6 | Aug 7 | Aug 8 | Aug 11 | Aug 12 | Aug 13 | |
|---|---|---|---|---|---|---|---|---|---|---|
| Jul | Aug | |||||||||
| 31 | 01 | 04 | 05 | 06 | 07 | 08 | 11 | 12 | 13 | |
| Technical Analysis: Buy or Sell? | ||||||||||
| 8-day SMA: | ||||||||||
| 20-day SMA: | ||||||||||
| 50-day SMA: | ||||||||||
| 200-day SMA: | ||||||||||
| 8-day EMA: | ||||||||||
| 20-day EMA: | ||||||||||
| 50-day EMA: | ||||||||||
| 200-day EMA: | ||||||||||
| MACD (12, 26): | ||||||||||
| Relative Strength Index (14 RSI): | ||||||||||
| Bollinger Bands (25): | ||||||||||
| Bollinger Bands (100): | ||||||||||